Point-of-care platform enabling simultaneous quantification of up to 8 biomarkers from 20-50 µl of capillary blood in 15 minutes. CE-IVD and IVDR certified technology designed for OEM integration and personalized medicine applications.
Manufactured by
Rainbach im Muehlkreis, Austria
GENSPEED Biotech GmbH – Rapid Multiplex Diagnostics in Laboratory Quality GENSPEED Biotech develops and manufactures rapid diagnostic tests that combine laboratory accuracy with true point-of-care convenience . Our proprietary GENSPEED® Multiplex Micro-ELISA Platform delivers quantitative, lab-quality results within 15–20 minutes from a single drop of capillary blood or other biological samples. The technology integrates microfluidics, chemiluminescence detection, and multiplexed ELISA chemistry in a compact, cartridge-based format. It enables simultaneous quantification of up to eight biomarkers, providing comprehensive diagnostic insights directly at the point of need — in pharmacies, doctors offices, clinics, and research laboratories. GENSPEED is IVDR-certified and already offers CE-marked assays such as the Vitamin D xPOC , FSME (TBE) IgG xPOC , COVID-19 IgG xPOC , and PerioPOC Pro tests. Current developments include multiplex assays for prosthetic joint infection (PJI) , process analytical testing for biopharmaceutical manufacturing (HEK293 HCP assay) and other applications. Our vision is to bring laboratory diagnostics to the point of care – enabling faster, data-driven medical decisions that improve patient outcomes and strengthen healthcare accessibility.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Eaglenos Sciences, Inc.
China · 1 relevant product
Response Biomedical
Canada · 1 relevant product
ReLIA Bioengineering(Jiangsu), Inc
China · 1 relevant product
Shenzhen Dymind Biotechnology Co.,Ltd.
China · 2 relevant products
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
Xenta Biomedical Science Co.,Ltd
China · 2 relevant products
Biomerica, Inc.
United States · 1 relevant product
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
BIOTYPE GmbH
Germany · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 1 relevant product
36 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 52 closest product alternatives
Eaglenos Sciences, Inc. · China
Point-of-care testing system for rapid, accurate detection and personalized health assessment. Integrates precision detection technology with health management protocols for decentralized diagnostic applications.
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
ReLIA Bioengineering(Jiangsu), Inc · China
A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Point-of-care testing platform for rapid disease detection and immediate clinical decision-making at bedside or clinic.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Shenzhen Dymind Biotechnology Co.,Ltd. · China
Rapid diagnostic testing system for immediate bedside and clinic-based testing. Enables quick clinical decision-making in emergency and primary care settings.
Xenta Biomedical Science Co.,Ltd · China
A proprietary dry-phase photoactivated chemiluminescence technology platform for point-of-care testing. Covers cardiovascular, inflammatory, tumor marker, hormone, and infectious disease diagnostics.
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
Guangzhou Wondfo Biotech Co., Ltd. · China
Point-of-care testing platform utilizing colloidal gold technology for rapid diagnostic applications. Enables quick detection and quantification of analytes in clinical settings without requiring laboratory infrastructure.
BIOTYPE GmbH · Germany
A proprietary platform enabling comprehensive multi-biomarker testing in one integrated workflow. Designed for robust molecular precision diagnostics in oncology and clinical research.
ZIODIA Co., Ltd. · South Korea
A diagnostic device platform based on MEMS (Micro-Electro-Mechanical System) core technology that enables precise control and detection of minute whole blood samples and implements real-time analysis at the point-of-care level through Lab-on-a-Chip technology. The platform is designed for medical chain diagnosis devices and related solutions.
guangzhou biotron technolongy co.,ltd · China
Point-of-care testing platform based on immunochemical principles for rapid on-site diagnostic testing without laboratory infrastructure requirements.
40 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products